Scott Canute Insider Profile
4 Followers
Scott Canute, Director at Akebia Therapeutics, holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 0.00 shares in Immunomedics (Ticker: IMMU), holds 13.70K shares in Akebia Therapeutics (Ticker: AKBA).
Scott Canute's Trading History
| ~FLXNFlexion Therapeutics | Nov 19, 2021 | ― | Uninformative Sell | 76.50K | $0.00 | |
| IMMUImmunomedics | Oct 23, 2020 | ― | Uninformative Sell | ― | $0.00 | |
| AKBAAkebia Therapeutics | Jun 10, 2019 | Director | Uninformative Buy | ― | $5.49K | |
| ONSIUOncobiologics Inc | Nov 30, 2016 | ― | Uninformative Buy | ― | $891.77K | |
| OTLKOutlook Therapeutics | Nov 14, 2016 | Director | Uninformative Buy | 234.78K | ― | |
| LLYEli Lilly & Co | ― | President, Mfg. Operations | ― | $66.89M | ||
| TARAProtara Therapeutics | ― | Director | ― | $0.00 | ||
| ONCROncorus | ― | ― | ― | ― |
You May Also Like
Scott Canute insider profile FAQ
What stocks does Scott Canute hold?
Scott Canute holds: AKBA, IMMU, ~FLXN, ONSIU, OTLK, ONCR, TARA, LLY stocks.
What was Scott Canute’s latest transaction?
Scott Canute’s latest transaction was an Uninformative Sell of $76.50K.
What is Scott Canute's role in Akebia Therapeutics?
Scott Canute's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
